Monday, September 7, 14:00 - 15:30
Hall F1

fresenius2IS.01 Industry Sponsored Lunch Symposia: Fresenius Medical Care
New Treatment Opportunities with Immunoadsorbtion Technology

Chairperson: Rudolf Valenta; Vienna, Austria

Treatment of Encephalitis with Immunoadsorption 
Nico Melzer; Münster, Germany

Apheresis in Autoimmune Disease 
Georg Böhmig; Vienna, Austria

New Option for Allergy Treatment. Why IgE?
Rudolf Valenta; Vienna, Austria

Questions & Answers

 

Monday, September 7, 14:00 - 15:30
Hall N

BeckmanCoulter2IS.02 Industry Sponsored Lunch Symposia: Beckman Coulter
New reagent and instrument concepts for your Immunology research

Chairperson: Andreas Böhmler; Krefeld, Germany

Innovative Technologies for phenotypic and functional Cell Characterization in Stem cell and Immune therapy
Lutz Uharek; Berlin, Germany

MAIT cells: their role in antibacterial immunity and beyond
Emmanuel Treiner; Toulouse, France

Small - smaller - smallest: Extracellular vesicles in inflammation
Andreas Spittler; Vienna, Austria

 

Monday, September 7, 19:15 - 20:15
Hall F1

thermofisherIS.03 Industry Sponsored Evening Symposium: Phadia Austria GmbH (Thermo Fisher Scientific)
Towards a molecular diagnosis of allergies

Chairpersons: Petra Zieglmayer; Vienna, Austria / Rudolf Valenta; Vienna, Austria

Molecular diagnosis of lgE-associated allergies
Marianne van Hage; Stockholm, Sweden

Early childhood lgE reactivity predicts later disease development
Magnus Wickman; Stockholm, Sweden

 

Monday, September 7, 19:15 - 20:15
Hall G

pfizerIS.04 Industry Sponsored Symposia: Pfizer
Personalized Vaccinology

Chairpersons: Ursula Wiedermann, Vienna, Austria / Martina Prelog, Würzburg, Germany

Vaccine responsiveness in patients with autoimmune disorders
Martina Prelog; Würzburg, Germany

Personalizing vaccination for high risk children
Rita Carsetti; Rome, Italy

Vaccine failures- why and what to do? 
Ursula Wiedermann; Vienna, Austria

 

Monday, September 7, 19:15 - 20:15
Hall N

IS.05 Industry Sponsored Evening Symposia Bristol-Myers Squibb (BMS) BMS
Immune checkpoint modulation – The standard in lung cancer and rheumatoid arthritis?

Chairperson: Christoph Zielinski; Vienna, Austria

Rational to Target Immune Checkpoints in Diseases
Eric Tartour; Paris, France

Evolving Immunotherapy Combinations for Cancer Treatment
Ignacio Melero; Pamplona, Spain

Abatacept: T-Cell Modulation in Rheumatoid Arthritis
Clemens-Maria Scheinecker; Vienna, Austria

 

Tuesday, September 8, 10:00 - 11:00
Hall N

FluidigmIS.06 Industry Sponsored Progress in Technology Session: Fluidigm
Connect cell diversity, stimulus and response with single-cell biology

Chairperson: Clare Rogers; Amsterdam, Netherlands

The future of single-cell biology
Mark Lynch, Dublin, Ireland / Robert Ellis; Amsterdam, Netherlands

Resolving bifurcation of Th1 and Tfh cell fates during Plasmodium infection using single-cell RNA sequencing
Tapio Lonnberg, Hinxton, United Kingdom

Defining immune effector and regulatory players in the newborn using a CyTOF® approach
Richard Lo-Man; Paris, France

  

Tuesday, September 8, 14:00 - 15:30
Hall F1

BDlogo2IS.07 Industry Sponsored Lunch Symposia: Becton Dickinson
Revealing Immune Cell Biology with Multicolor Flow Cytometry

Chairperson: Nicolas Quoix; Erembodegem, Belgium

Optimizing Strategies for Reliable Multicolor Flow Cytometry Data
Guerric Epron; Erembodegem, Belgium

Nutrient control of stem cell and T cell differentiation
Naomi Taylor; Montpellier, France